|
|
???tair.name??? >
???browser.page.title.author???
|
"lane hy"???jsp.browse.items-by-author.description???
Showing items 26-43 of 43 (2 Page(s) Totally)
<< < 1 2
View [10|25|50] records per page
| 中國醫藥大學 |
2004 |
Effects of dopamine D-2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function
|
Lane, HY; Lee, CC; Chang, YC; Lu, CT; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2004 |
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia
|
Chiu, CC; Lane, HY; Huang, MC; Liu, HC; Jann, MW; Hon, YY; Chang, WH; Lu, ML |
| 中國醫藥大學 |
2003 |
Adjunctive fluvoxamine with clozapine
|
Lu, ML; Lane, HY |
| 中國醫藥大學 |
2003 |
QTc intervals are not prolonged in young healthy patients with recommended dosage of risperidone
|
Chiu, CC; Lane, HY; Huang, MC; Chang, WH |
| 中國醫藥大學 |
2003 |
Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia
|
Lane, HY; Chang, YC; Cheng, YC; Liu, GC; Lin, XR; Chang, WH |
| 中國醫藥大學 |
2003 |
Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia
|
Lane, HY; Chang, YC; Cheng, YC; Liu, GC; Lin, XR; Chang, WH |
| 中國醫藥大學 |
2003 |
Refining pharmacogenetic research in schizophrenia: Control for patient-related variables
|
Lane, HY; Chang, YC; Huang, CL; Chang, WH |
| 中國醫藥大學 |
2003 |
Refining pharmacogenetic research in schizophrenia: Control for patient-related variables
|
Lane, HY; Chang, YC; Huang, CL; Chang, WH |
| 國立臺灣大學 |
2002-05 |
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.
|
Lane, HY; Guo, SC; Hwang, TJ; Chen, YS; Cheng, JJ; Lee, YC; Hong, CJ; Hwu, HG; Chang, WH |
| 中國醫藥大學 |
2002 |
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: A pilot study
|
Lane, HY; Guo, SC; Hwang, TJ; Chen, YS; Cheng, JJ; Lee, YC; Hong, CJ; Hwu, HG; Chang, WH |
| 中國醫藥大學 |
2002 |
Dosing strategies of clozapine-fluvoxamine cotreatment
|
Lu, ML; Lane, HY; Jann, MW; Chang, WH |
| 中國醫藥大學 |
2002 |
Fluvoxamine-clozapine interaction: Time-dependent?
|
Lu, ML; Lane, HY; Chang, WH |
| 中國醫藥大學 |
2002 |
Association of risperidone treatment response with a polymorphism in the 5-HT2A receptor gene
|
Lane, HY; Chang, YC; Chiu, CC; Chen, ML; Hsieh, MH; Chang, WH |
| 中國醫藥大學 |
2002 |
Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: Analyses with rigorous statistics
|
Lane, HY; Chang, YC; Chiu, CC; Chen, TT; Lee, SH; Chang, WH |
| 中國醫藥大學 |
2002 |
Association of risperidone treatment response with a polymorphism in the 5-HT2A receptor gene
|
Lane, HY; Chang, YC; Chiu, CC; Chen, ML; Hsieh, MH; Chang, WH |
| 國立臺灣大學 |
2001-05 |
A double-blinded study on efficacy and safety of olanzapine versus haloperidol in the treatment of schizophrenic patients.
|
Hong, CJ; Cheng, JJ; Hwang, TJ; Chen, YS; Guo, SC; Lane, HY; Lee, YC; Zhang, F; Chnag, WH; Tran, P; Hwu, HG |
| 臺北醫學大學 |
1999 |
Seizures after Discontinuation of Low-Dose Lorazepam From Originally Seizure-Free Clozapine Regimen: Combined Effects?
|
蘇冠賓; Lane HY; Su KP; Chang WH |
| 臺北醫學大學 |
1998 |
Elevated plasma clozapine concentrations after phenobarbital discontinuation
|
蘇冠賓; Lane HY; Su KP; Chang WH |
Showing items 26-43 of 43 (2 Page(s) Totally)
<< < 1 2
View [10|25|50] records per page
|
